Functional brain alterations in anxious depression: Insights from whole-brain fMRI and meta-analysis.

Dialogues Clin NeurosciJan 20, 2026 (epub)
Clinical ResearchPsychiatryOpen access

Hao Huang, Zhiwei Guo, Xiqin Yang et al.

✦ AI-curated · Sources linked

In 30 seconds

This meta-analysis examined whole-brain neuroimaging differences in anxious major depressive disorder (aMDD), compared with pure major depressive disorder (MDD) and healthy controls, and explored gender differences. It included 11 studies with 829 people with aMDD, 681 with MDD, and 865 healthy controls. Compared with MDD, aMDD was associated with increased functional alteration in the left middle temporal gyrus. Comparisons with healthy controls identified alterations in the anterior commissure and right middle frontal gyrus; meta-regression also found sex-related regional activity differences in females with aMDD.

Key findings

  • Across 11 studies, the meta-analysis included 829 aMDD patients, 681 MDD patients, and 865 healthy controls.
  • Compared with MDD, aMDD was associated with increased functional alteration in the left middle temporal gyrus.
  • Compared with healthy controls, aMDD showed increased functional alteration in the anterior commissure and decreased alteration in the right middle frontal gyrus.
  • In females with aMDD versus controls, meta-regression found heightened activity in the left middle cingulate and right anterior thalamic regions, and weakened activity in the left rolandic operculum.

Why it matters

The findings suggest that anxious depression may have functional brain patterns distinguishable from both MDD without anxiety and healthy status, with additional sex-related differences. These results may help guide research into neurobiological markers and the heterogeneity of depressive disorders, but the reported regional associations do not establish diagnostic utility or explain underlying mechanisms.

What to keep in mind

The analysis synthesised 11 studies, and the abstract does not report validation of these regional findings as diagnostic markers.

Source

Published in Dialogues Clin Neurosci. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.